Singh K - Search Results

1

Liposome-polyethylenimine complexes for the effective delivery of HuR siRNA in the treatment of diabetic retinopathy.

Supe S, Upadhya A, Tripathi S, Dighe V, Singh K. Supe S, et al. Among authors: singh k. Drug Deliv Transl Res. 2023 Jun;13(6):1675-1698. doi: 10.1007/s13346-022-01281-9. Epub 2023 Jan 11. Drug Deliv Transl Res. 2023. PMID: 36630075

2

Development of dorzolamide loaded 6-o-carboxymethyl chitosan nanoparticles for open angle glaucoma.

Shinde U, Ahmed MH, Singh K. Shinde U, et al. Among authors: singh k. J Drug Deliv. 2013;2013:562727. doi: 10.1155/2013/562727. Epub 2013 Oct 10. J Drug Deliv. 2013. PMID: 24222858 Free PMC article.

3

Role of small interfering RNA (siRNA) in targeting ocular neovascularization: A review.

Supe S, Upadhya A, Singh K. Supe S, et al. Among authors: singh k. Exp Eye Res. 2021 Jan;202:108329. doi: 10.1016/j.exer.2020.108329. Epub 2020 Oct 23. Exp Eye Res. 2021. PMID: 33198953 Review.

4

Formulation development and evaluation of therapeutic contact lens loaded with ganciclovir.

Harsolekar M, Ansari M, Supe S, Singh K. Harsolekar M, et al. Among authors: singh k. Int Ophthalmol. 2023 Jul;43(7):2225-2236. doi: 10.1007/s10792-022-02618-6. Epub 2023 Jan 2. Int Ophthalmol. 2023. PMID: 36593425

5

Analysis of RNA Interference Targeted Against Human Antigen R (HuR) to Reduce Vascular Endothelial Growth Factor (VEGF) Protein Expression in Human Retinal Pigment Epithelial Cells.

Supe S, Dighe V, Upadhya A, Singh K. Supe S, et al. Among authors: singh k. Mol Biotechnol. 2024 Oct;66(10):2972-2984. doi: 10.1007/s12033-023-00913-w. Epub 2023 Oct 19. Mol Biotechnol. 2024. PMID: 37856012

6

Development and Characterization of Modified Chitosan Lipopolyplex for an Effective siRNA Delivery.

Supe S, Upadhya A, Dighe V, Singh K. Supe S, et al. Among authors: singh k. AAPS PharmSciTech. 2024 Jan 8;25(1):13. doi: 10.1208/s12249-023-02728-z. AAPS PharmSciTech. 2024. PMID: 38191947

7

Therapeutic Management and New Upcoming Approaches for Age Related Macular Degeneration.

Shetty S, Singh K, Barve K. Shetty S, et al. Among authors: singh k. Curr Drug Res Rev. 2023 Sep 28. doi: 10.2174/0125899775250144230920053548. Online ahead of print. Curr Drug Res Rev. 2023. PMID: 37779414

8

Advanced Technologies of Drug Delivery to the Posterior Eye Segment Targeting Angiogenesis and Ocular Cancer.

Ansari M, Kulkarni YA, Singh K. Ansari M, et al. Among authors: singh k. Crit Rev Ther Drug Carrier Syst. 2024;41(1):85-124. doi: 10.1615/CritRevTherDrugCarrierSyst.2023045298. Crit Rev Ther Drug Carrier Syst. 2024. PMID: 37824419 Review.

9

Development and Evaluation of Novel Polymeric Nanoparticles of Brimonidine Tartrate.

Singh KH, Shinde UA. Singh KH, et al. Curr Drug Deliv. 2010 Jul;7(3):244-51. doi: 10.2174/156720110791561008. Curr Drug Deliv. 2010. PMID: 20497099

10

Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.

Shinde UA, Joshi PN, Jain DD, Singh K. Shinde UA, et al. Among authors: singh k. Curr Eye Res. 2019 May;44(5):575-582. doi: 10.1080/02713683.2019.1567793. Epub 2019 Jan 28. Curr Eye Res. 2019. PMID: 30632402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,996 results

Search Page

Filters